HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+14.9%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$272M
AUM Growth
+$272M
(+4.9%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
27.33%
Holding
177
New
29
Increased
50
Reduced
55
Closed
31
Top Buys
| 1 |
Viridian Therapeutics
VRDN
|
$4.25M |
| 2 |
Advanced Micro Devices
AMD
|
$2.19M |
| 3 |
Celldex Therapeutics
CLDX
|
$2.17M |
| 4 |
Ferguson
FERG
|
$2.15M |
| 5 |
Mineralys Therapeutics
MLYS
|
$2.03M |
Top Sells
| 1 |
Albertsons Companies
ACI
|
$4.15M |
| 2 |
GE Vernova
GEV
|
$3.07M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$3.03M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$2.1M |
| 5 |
Bausch Health
BHC
|
$2.03M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Technology | 22.09% |
| 3 | Industrials | 8.52% |
| 4 | Financials | 6.08% |
| 5 | Consumer Discretionary | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intuit
INTU
$187B
| $2.57M | 0.94% |
3,263
-600
| -16% | -$473K |
|
27
Revolution Medicines
RVMD
$7.43B
| $2.5M | 0.92% |
68,048
-5,704
| -8% | -$210K |
|
28
NVIDIA
NVDA
$4.15T
| $2.48M | 0.91% |
15,700
+1,100
| +8% | +$174K |
|
29
Quanta Services
PWR
$55.8B
| $2.42M | 0.89% |
6,400
-1,700
| -21% | -$643K |
|
30
Arcellx
ACLX
$3.95B
| $2.35M | 0.86% |
35,714
-11,782
| -25% | -$776K |
|
31
Agios Pharmaceuticals
AGIO
$2.36B
| $2.33M | 0.86% |
70,127
+26,022
| +59% | +$865K |
|
32
Meta Platforms (Facebook)
META
$1.85T
| $2.29M | 0.84% |
3,100
-100
| -3% | -$73.8K |
|
33
Visa
V
$681B
| $2.28M | 0.84% |
6,427
+300
| +5% | +$107K |
|
34
Cytokinetics
CYTK
$5.98B
| $2.27M | 0.83% |
68,652
+23,903
| +53% | +$790K |
|
35
Mastercard
MA
$536B
| $2.25M | 0.83% |
4,000
+300
| +8% | +$169K |
|
36
3M
MMM
$81B
| $2.19M | 0.81% |
14,400
+900
| +7% | +$137K |
|
|
37
Advanced Micro Devices
AMD
$263B
| $2.19M | 0.8% |
+15,400
| New | +$2.19M |
|
|
38
Celldex Therapeutics
CLDX
$1.57B
| $2.17M | 0.8% |
+106,553
| New | +$2.17M |
|
|
39
Ferguson
FERG
$46.1B
| $2.15M | 0.79% |
+9,878
| New | +$2.15M |
|
|
40
GE Vernova
GEV
$157B
| $2.12M | 0.78% |
4,000
-5,800
| -59% | -$3.07M |
|
41
Booking.com
BKNG
$181B
| $2.07M | 0.76% |
357
| – | – |
|
42
Cogent Biosciences
COGT
$1.83B
| $2.03M | 0.75% |
283,186
+3,513
| +1% | +$25.2K |
|
|
43
Mineralys Therapeutics
MLYS
$1.94B
| $2.03M | 0.75% |
+150,138
| New | +$2.03M |
|
44
Synopsys
SNPS
$110B
| $2M | 0.73% |
3,900
+800
| +26% | +$410K |
|
45
Lyft
LYFT
$7.02B
| $1.98M | 0.73% |
+125,800
| New | +$1.98M |
|
46
Apogee Therapeutics
APGE
$2.27B
| $1.96M | 0.72% |
45,052
+1,862
| +4% | +$80.9K |
|
47
Cleveland-Cliffs
CLF
$5.18B
| $1.94M | 0.71% |
+255,600
| New | +$1.94M |
|
48
Amphenol
APH
$135B
| $1.88M | 0.69% |
19,000
-3,900
| -17% | -$385K |
|
49
MasTec
MTZ
$14.2B
| $1.87M | 0.69% |
11,000
-5,300
| -33% | -$903K |
|
|
QXO
50
QXO Inc
QXO
$13.8B
| $1.82M | 0.67% |
84,500
-19,000
| -18% | -$409K |
|